Interplay between hepatitis B virus and TLR2-mediated innate immune responses: Can restoration of TLR2 functions be a new therapeutic option?

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 486-489

  Durantel, David ^a,b   Zoulim, Fabien ^a,b,c  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NUCLEOSIDE ANALOG; PATTERN RECOGNITION RECEPTOR; RAPAMYCIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CELL SURFACE; CYTOKINE PRODUCTION; CYTOSOL; DENDRITIC CELL; EDITORIAL; ENDOPLASMIC RETICULUM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; MEDIATOR; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEROLOGY; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; VERTICAL TRANSMISSION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIPOPEPTIDES; TOLL-LIKE RECEPTOR 2;

EID: 84865118780     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.019     Document Type: Editorial

References (21)

1. M. Lambotin, S. Raghuraman, F. Stoll-Keller, T.F. Baumert, and H. Barth A look behind closed doors: interaction of persistent viruses with dendritic cells Nat Rev Microbiol 8 2010 350 360
2. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 2005 215 229 (Pubitemid 40364823)
3. B.J. McMahon The natural history of chronic hepatitis B virus infection Hepatology 49 2009 S45 S55
4. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
5. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
6. A.G. Bowie, and L. Unterholzner Viral evasion and subversion of pattern-recognition receptor signalling Nat Rev Immunol 8 2008 911 922
7. K. Visvanathan, N.A. Skinner, A.J. Thompson, S.M. Riordan, V. Sozzi, and R. Edwards Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein Hepatology 45 2007 102 110 (Pubitemid 46150869)
8. D. Milich, and T.J. Liang Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection Hepatology 38 2003 1075 1086 (Pubitemid 37314815)
9. M. Isogawa, M.D. Robek, Y. Furuichi, and F.V. Chisari Toll-like receptor signaling inhibits hepatitis B virus replication in vivo J Virol 79 2005 7269 7272 (Pubitemid 40677357)
10. I.E. Vincent, C. Zannetti, J. Lucifora, H. Norder, U. Protzer, and P. Hainaut Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells PLoS One 6 2011 e26315
11. J. Wu, Z. Meng, M. Jiang, R. Pei, M. Trippler, and R. Broering Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells Hepatology 49 2009 1132 1140
12. Q. Xie, H.C. Shen, N.N. Jia, H. Wang, L.Y. Lin, and B.Y. An Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9 Microbes Infect 11 2009 515 523
13. I. Hirsch, C. Caux, U. Hasan, N. Bendriss-Vermare, and D. Olive Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer Trends Immunol 31 2010 391 397
14. T. Lang, C. Lo, N. Skinner, S. Locarnini, K. Visvanathan, and A. Mansell The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway J Hepatol 55 2011 762 769
15. L.G. Guidotti, B. Matzke, C. Pasquinelli, J.M. Shoenberger, C.E. Rogler, and F.V. Chisari The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice J Virol 70 1996 7056 7061 (Pubitemid 26307420)
16. M. Duriez, J.M. Rossignol, and D. Sitterlin The hepatitis B virus precore protein is retrotransported from endoplasmic reticulum (ER) to cytosol through the ER-associated degradation pathway J Biol Chem 283 2008 32352 32360
17. X. Zhang, Z. Ma, H. Liu, J. Liu, Z. Meng, and R. Broering Role of Toll-like receptor 2 in the immune response against hepadnaviral infection J Hepatol 57 2012 522 528
18. M. Biermer, R. Puro, and R.J. Schneider Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB J Virol 77 2003 4033 4042 (Pubitemid 36350944)
19. A. Cooper, G. Tal, O. Lider, and Y. Shaul Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2 J Immunol 175 2005 3165 3176 (Pubitemid 41170538)
20. A. Bardens, T. Doring, J. Stieler, and R. Prange Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner Cell Microbiol 13 2011 602 619
21. M. Hosel, M. Quasdorff, K. Wiegmann, D. Webb, U. Zedler, and M. Broxtermann Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection Hepatology 50 2009 1773 1782